Reporting owner · CIK 0001609493

Mpm BioVentures 2014 (B), L.P.

SEC Form 4 history across 1 companies, 12 transactions and 4 filings.

10%Entrada Therapeutics, Inc.
Open-market transaction mix0% buys0 buys · 12 sales

Available history · Aug 24, 2026 – Sep 09, 2026

Filings4Form 4 records
Buying$00 purchases
Selling$3.6M12 sales
Net value−$3.6MBuys minus sells · disclosed values

Latest insider transactions

Form 4 filings from available history.
Mpm BioVentures 2014 (B), L.P. transactions · 20 per page
CompanyInsiderActivityDisclosed valueFiled (ET)
TRDAEntrada Therapeutics, Inc.
Mpm BioVentures 2014 (B), L.P.10%S · saleSEC filing ↗-$205kView disclosure →
TRDAEntrada Therapeutics, Inc.
Mpm BioVentures 2014 (B), L.P.10%S · saleSEC filing ↗-$1.42MView disclosure →
TRDAEntrada Therapeutics, Inc.
Mpm BioVentures 2014 (B), L.P.10%S · saleSEC filing ↗-$273kView disclosure →
TRDAEntrada Therapeutics, Inc.
Mpm BioVentures 2014 (B), L.P.10%S · saleSEC filing ↗-$231kView disclosure →
TRDAEntrada Therapeutics, Inc.
Mpm BioVentures 2014 (B), L.P.10%S · saleSEC filing ↗-$180kView disclosure →
TRDAEntrada Therapeutics, Inc.
Mpm BioVentures 2014 (B), L.P.10%S · saleSEC filing ↗-$205kView disclosure →
TRDAEntrada Therapeutics, Inc.
Mpm BioVentures 2014 (B), L.P.10%S · saleSEC filing ↗-$309kView disclosure →
TRDAEntrada Therapeutics, Inc.
Mpm BioVentures 2014 (B), L.P.10%S · saleSEC filing ↗-$26.1kView disclosure →
TRDAEntrada Therapeutics, Inc.
Mpm BioVentures 2014 (B), L.P.10%S · saleSEC filing ↗-$280kView disclosure →
TRDAEntrada Therapeutics, Inc.
Mpm BioVentures 2014 (B), L.P.10%S · saleSEC filing ↗-$102kView disclosure →
TRDAEntrada Therapeutics, Inc.
Mpm BioVentures 2014 (B), L.P.10%S · saleSEC filing ↗-$199kView disclosure →
TRDAEntrada Therapeutics, Inc.
Mpm BioVentures 2014 (B), L.P.10%S · saleSEC filing ↗-$158kView disclosure →

Latest Form 4 facts

Quick context from source filings

Latest open-market transaction

sale at Entrada Therapeutics, Inc. on Sep 09, 2026 valued at $205,608.

Review SEC filing
Latest buy

No open-market insider purchase is available.

Latest sale

sale at Entrada Therapeutics, Inc. on Sep 09, 2026 valued at $205,608.

Review SEC filing

Monthly open-market activity

Last 2 reported months · purchases and sales

View exact monthly values
Monthly open-market source values
MonthPurchasesSalesBuy valueSale valueNet value
Aug 202606$0.00$1,077,322.98-$1,077,322.98
Sep 202606$0.00$2,523,146.69-$2,523,146.69

Net value is disclosed purchases minus sales, not profit. A dash means the value is unavailable.

Ownership and transaction size

Ownership and ticket size

Average P/S size$300K
Median P/S size$205.5K
Direct0
Indirect12
Sep 09, 2026sale

Filing-only signals

Deterministic matches in this insider's history

Associated companies

Companies in the disclosed reporting history

Open-market buy performance

90-day forward return on this insider's open-market purchases

90d forward
No open-market purchases in available history

A 90-day purchase return requires an open-market buy. No eligible purchases are recorded in this history.

Disclosed ownership

How reported shareholdings evolved

Non-derivative shares held after reported transactions—not stock prices or a complete portfolio.

12 observations · Aug 24, 2026 – Sep 9, 2026. Window ends at the latest available report, not today.

Selected observation · Sep 9, 20263,885,115 shares reported
Inspect transaction
View exact observations and source transactions
Transaction dateShares held afterFiledSource
Aug 24, 20264,359,439Aug 27, 2026View transaction
Aug 25, 20264,332,917Aug 27, 2026View transaction
Aug 26, 20264,318,348Aug 27, 2026View transaction
Aug 27, 20264,279,426Aug 31, 2026View transaction
Aug 28, 20264,275,693Aug 31, 2026View transaction
Aug 31, 20264,231,434Aug 31, 2026View transaction
Sep 1, 20264,202,346Sep 3, 2026View transaction
Sep 2, 20264,177,215Sep 3, 2026View transaction
Sep 3, 20264,144,952Sep 3, 2026View transaction
Sep 4, 20264,106,452Sep 9, 2026View transaction
Sep 8, 20263,913,952Sep 9, 2026View transaction
Sep 9, 20263,885,115Sep 9, 2026View transaction

Securities and direct/indirect ownership contexts are kept separate and never summed. Joint filings may associate the same disclosed row with multiple owners. Unknown values are omitted, not treated as zero. Lines connect observations for readability; they do not establish holdings between filings, cost basis, or current ownership. Amendments and stock splits require reviewing the source.

Mpm BioVentures 2014 (B), L.P. Insider Activity FAQ

SEC Form 4 context

Who is Mpm BioVentures 2014 (B), L.P.?

Mpm BioVentures 2014 (B), L.P. is a reporting owner in SEC Form 4 filings with reporting owner CIK 0001609493.

Which companies has Mpm BioVentures 2014 (B), L.P. reported transactions for?

Entrada Therapeutics, Inc.

When was Mpm BioVentures 2014 (B), L.P.'s latest insider buy?

No open-market insider purchase is available for this period.

When was Mpm BioVentures 2014 (B), L.P.'s latest insider sale?

sale at Entrada Therapeutics, Inc. on Sep 09, 2026 valued at $205,608.

Where can I see the original SEC filings?

Each transaction row links directly to the source SEC filing so the reported Form 4 details can be reviewed.

Are performance metrics included?

The profile shows average and median 90-day stock returns after open-market purchases when price coverage is available. These are unadjusted stock returns, not realized trading gains. Win rates, benchmark-adjusted returns and conviction scores are not calculated.